Dosing and Adverse Reaction Management for LENVIMA®
This program will review the management of adverse reactions with dose modifications, interruptions, and discontinuations.
Gabriel Schwartz, NP
Department of GI Medical Oncology
San Francisco, CA
To register to attend this program, enter program code 60156
at http://rsvp.esi-speakerprograms.com or call (877) 869-2854